Dr. Jaclyn Bennet

Jaclyn Bennet is a clinical researcher focused on infectious diseases, with expertise spanning tuberculosis, hepatitis C, and HIV. Her work is closely aligned with major international trial networks, contributing to multicentre studies across Africa, Asia, Europe, and the Americas. She has played an important role in advancing simplified and patient-centred treatment strategies in diverse global settings.

Her research on tuberculosis has addressed treatment shortening, drug-resistant TB regimens, and risk stratification to optimize outcomes while reducing toxicity. Contributions to landmark trials in leading medical journals have helped inform policy on bedaquiline-containing regimens and individualized treatment approaches. Additional work on spirometry at TB diagnosis highlights the burden of post-TB lung disease and the need for improved respiratory assessment.

In viral infections, Bennet has examined minimal monitoring strategies for hepatitis C therapy and quality-of-life outcomes following direct-acting antiviral treatment, supporting scalable elimination efforts. She has also contributed to studies on COVID-19 vaccine immunogenicity and HIV phylogenetics, reflecting strengths in global trial implementation, translational analysis, and public health impact.